PortfoliosLab logoPortfoliosLab logo
Balanced-Target
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Diversification

Asset Allocation


GLD 10.00%VSMGX 45.00%ITDE 45.00%CommodityCommodityMulti-AssetMulti-Asset

S&P 500 Index

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Balanced-Target, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.


Loading graphics...

The earliest data available for this chart is Oct 19, 2023, corresponding to the inception date of ITDE

Returns By Period


1D1MYTD6M1Y3Y*5Y*10Y*
Benchmark
S&P 500 Index
0.72%-3.54%-3.95%-2.09%15.95%16.96%10.34%12.24%
Portfolio
Balanced-Target
0.51%-3.26%0.41%3.39%19.51%
VSMGX
Vanguard LifeStrategy Moderate Growth Fund
1.81%-4.25%-1.04%0.93%14.43%13.22%6.60%8.13%
ITDE
Ishares Lifepath Target Date 2045 ETF
0.73%-4.39%-0.34%1.93%19.19%
GLD
SPDR Gold Shares
1.75%-10.65%10.47%22.97%52.25%33.69%22.00%14.11%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Oct 20, 2023, Balanced-Target's average daily return is +0.08%, while the average monthly return is +1.52%. At this rate, your investment would double in approximately 3.8 years.

Historically, 77% of months were positive and 23% were negative. The best month was Nov 2023 with a return of +7.4%, while the worst month was Mar 2026 at -5.8%. The longest winning streak lasted 11 consecutive months, and the longest losing streak was 1 months.

On a daily basis, Balanced-Target closed higher 58% of trading days. The best single day was Apr 9, 2025 with a return of +5.8%, while the worst single day was Apr 4, 2025 at -4.0%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20263.40%2.61%-5.84%0.51%0.41%
20252.90%0.36%-1.47%1.16%3.59%3.31%0.46%2.76%3.74%1.73%0.87%0.77%22.00%
2024-0.30%2.62%3.23%-2.72%3.40%1.30%2.61%2.17%2.36%-1.56%2.69%-0.62%16.02%
2023-0.88%7.39%4.71%11.46%

Benchmark Metrics

Balanced-Target has an annualized alpha of 8.30%, beta of 0.61, and R² of 0.81 versus S&P 500 Index. Calculated based on daily prices since October 20, 2023.

  • This portfolio participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (78.25%) than losses (38.57%) — typical of diversified or defensive assets.
  • This portfolio generated an annualized alpha of 8.30% versus S&P 500 Index — delivering returns beyond what market exposure alone would predict.
  • Beta of 0.61 indicates this portfolio moves significantly less than S&P 500 Index — a genuinely defensive profile with reduced participation in both market rallies and downturns.

Alpha
8.30%
Beta
0.61
0.81
Upside Capture
78.25%
Downside Capture
38.57%

Expense Ratio

Balanced-Target has an expense ratio of 0.15%, which is considered low. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.


Return for Risk

Risk / Return Rank

Balanced-Target ranks 76 for risk / return — better than 76% of portfolios on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


Balanced-Target Risk / Return Rank: 7676
Overall Rank
Balanced-Target Sharpe Ratio Rank: 7777
Sharpe Ratio Rank
Balanced-Target Sortino Ratio Rank: 7979
Sortino Ratio Rank
Balanced-Target Omega Ratio Rank: 8080
Omega Ratio Rank
Balanced-Target Calmar Ratio Rank: 7070
Calmar Ratio Rank
Balanced-Target Martin Ratio Rank: 7272
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics


PortfolioBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

1.64

0.92

+0.73

Sortino ratio

Return per unit of downside risk

2.34

1.41

+0.93

Omega ratio

Gain probability vs. loss probability

1.35

1.21

+0.13

Calmar ratio

Return relative to maximum drawdown

2.37

1.41

+0.95

Martin ratio

Return relative to average drawdown

10.22

6.61

+3.61


How much return does each position deliver for the risk it carries? Higher values mean better reward for the risk taken.

Risk / Return RankSharpe ratioSortino ratioOmega ratioCalmar ratioMartin ratio
VSMGX
Vanguard LifeStrategy Moderate Growth Fund
811.452.081.302.058.78
ITDE
Ishares Lifepath Target Date 2045 ETF
711.281.891.281.808.45
GLD
SPDR Gold Shares
851.892.311.352.709.90

Sharpe Ratio

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Balanced-Target Sharpe ratios as of Apr 2, 2026 (values are recalculated daily):

  • 1-Year: 1.64
  • All Time: 1.98

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 1.00 to 1.70, this portfolio's current Sharpe ratio falls between the 25th and 75th percentiles. This indicates that its risk-adjusted performance is in line with the majority of portfolios, suggesting a balanced approach to risk and return—likely suitable for a wide range of investors.

The chart below shows the rolling Sharpe ratio of Balanced-Target compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.


Loading graphics...

Dividends

Dividend yield

Balanced-Target provided a 3.22% dividend yield over the last twelve months.


TTM20252024202320222021202020192018201720162015
Portfolio3.22%3.20%5.91%2.20%1.20%1.74%1.55%1.13%1.85%0.49%1.02%1.75%
VSMGX
Vanguard LifeStrategy Moderate Growth Fund
5.30%5.25%11.49%4.01%2.66%3.86%3.46%2.52%4.11%1.09%2.26%3.89%
ITDE
Ishares Lifepath Target Date 2045 ETF
1.86%1.86%1.64%0.87%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
GLD
SPDR Gold Shares
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Balanced-Target. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Balanced-Target was 10.77%, occurring on Apr 8, 2025. Recovery took 23 trading sessions.

The current Balanced-Target drawdown is 5.45%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-10.77%Feb 19, 202535Apr 8, 202523May 12, 202558
-8.09%Feb 26, 202623Mar 30, 2026
-5.15%Jul 17, 202414Aug 5, 202410Aug 19, 202424
-3.54%Dec 12, 20246Dec 19, 202418Jan 17, 202524
-3.41%Nov 13, 20256Nov 20, 20259Dec 4, 202515

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Diversification

Diversification Metrics


Number of Effective Assets

The portfolio contains 3 assets, with an effective number of assets of 2.41, reflecting the diversification based on asset allocation. This number of effective assets suggests a highly concentrated portfolio, where a few assets dominate the allocation, potentially increasing the portfolio's risk due to lack of diversification.

Asset Correlations Table

The table below displays the correlation coefficients between the individual components of the portfolio, the entire portfolio, and the chosen benchmark.

BenchmarkGLDVSMGXITDEPortfolio
Benchmark1.000.110.910.940.88
GLD0.111.000.230.220.40
VSMGX0.910.231.000.970.97
ITDE0.940.220.971.000.96
Portfolio0.880.400.970.961.00
The correlation results are calculated based on daily price changes starting from Oct 20, 2023